Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Honeur (Heamatology Outcomes Network in Europe): A Federated Model to Support Real World Data Research in Hematology

Kristina Bardenheuer, MSc Epi, Alun Passey, PhDTranslational Oncology, Maria d'Errico, PhDPhysics, Barbara Millier, MBA, Carine Guinard-Azadian, MD, Johan Aschan, MD PhD, Michel van Speybroeck, MSc

Blood (2018) 132 (Supplement 1): 4839.

https://doi.org/10.1182/blood-2018-99-111093

Published: 2018

Journal Articles

Is Multiple Myeloma a Chronic Disease? A Population Based Study Comparing 1843 Patients to a Matched Swedish Population.

Hareth Nahi, Johan Liwing, Anders Aldrin, Johan Andreasson, Cecilie Blimark, MD, Kristina Carlson, Jon Enestig, Max Flogegård, Karin Forsberg, Astrid Gruber, MD, PhD, Peter Johansson, MD, PhD, Helene Kviele, Birgitta Lauri, Ulf-Henrik Mellqvist, MD, PhD, Per Näsman, Agneta Swedin, Magnus Svensson, Katarina Uttervall, MD, PhD-student, Johan Aschan, MD, PhD

Blood (2012) 120 (21): 2970.

https://doi.org/10.1182/blood.V120.21.2970.2970

Published: 2012

Journal Articles

Is Renal Impairment Still a Poor Prognostic Marker in Myeloma Care?: A Population Based Study Including 1542 Patients

Katarina Uttervall, MD, PhD-student, Johan Andreasson, Johan Liwing, Per Näsman, Johan Aschan, MD, PhD, Hareth Nahi

Blood (2012) 120 (21): 5033.

https://doi.org/10.1182/blood.V120.21.5033.5033

Published: 2012

Journal Articles

Follow-up of Real Life Treated Multiple Myeloma Patients: Response, Disease Progression and Overall Survival,

Hareth Nahi, Johan Liwing, Katarina Uttervall, Johan Andreasson, Astrid Gruber, MD, PhD, Per Näsman, Johan Aschan

Blood (2011) 118 (21): 3937.

https://doi.org/10.1182/blood.V118.21.3937.3937

Published: 2011

Journal Articles

Optimal Treatment Sequencing In Multiple Myeloma: An Exploratory Modeling Approach

Bart Heeg, Michel van Agthoven, Johan Liwing, Ulf-Henrik Mellqvist, Torben Plesner, Floris Logman, Verena Donatz, Johan Aschan, Hermann Einsele, Martin Kropff, Maarten Treur, Mirjam Barendse, Jean-Luc Harousseau, Antonio Palumbo, Pieter Sonneveld

Blood (2010) 116 (21): 3046.

https://doi.org/10.1182/blood.V116.21.3046.3046

Published: 2010

Journal Articles

Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients after Stem Cell Transplantation.

Gayane Avetisyan, MD, Johan Aschan, MD, PhD, Moustapha Hassan, Per Ljungman

Blood (2007) 110 (11): 2993.

https://doi.org/10.1182/blood.V110.11.2993.2993

Published: 2007

Journal Articles

Impact of Conditioning on the Outcome of Allografting in Myelofibrosis with Myeloid Metaplasia: Better Survival with Reduced Intensity Approach in Patients ≥50 Years.

Vikas Gupta, Nicolaus Kroger, Johan Aschan, Brian Leber, Christopher Dalley, Mitchell Sabloff, Jeffrey H. Lipton, Hans Messner, Wei Xu, Mats Brune

Blood (2007) 110 (11): 1095.

https://doi.org/10.1182/blood.V110.11.1095.1095

Published: 2007

Journal Articles

Fatal Infectious Complications Developing Late after Allogeneic Stem Cell Transplantation.

Andreas Bjorklund, MD, Johan Aschan, Olle Ringden, Jacek H. Winiarski, Per T. Ljungman

Blood (2005) 106 (11): 3239.

https://doi.org/10.1182/blood.V106.11.3239.3239

Published: 2005

Journal Articles

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

Mehmet Uzunel, Jonas Mattsson, Mats Brune, Jan-Erik Johansson, Johan Aschan, Olle Ringdén

Blood (2003) 101 (2): 469–472.

https://doi.org/10.1182/blood-2002-02-0571

Published: 2003

Journal Articles

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

Britt-Marie Svahn, Mats Remberger, Karl-Erik Myrbäck, Katarina Holmberg, Britta Eriksson, Patrik Hentschke, Johan Aschan, Lisbeth Barkholt, Olle Ringdén

Blood (2002) 100 (13): 4317–4324.

https://doi.org/10.1182/blood-2002-03-0801

Published: 2002

Journal Articles

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

Mats Remberger, Oolle Ringdén, Igor-Wolfgang Blau, Hellmut Ottinger, Bernhard Kremens, Micheil G. Kiehl, Johan Aschan, Dietrich W. Beelen, Nadezda Basara, Gunilla Kumlien, Axel A. Fauser, Volker Runde

Blood (2001) 98 (6): 1739–1745.

https://doi.org/10.1182/blood.V98.6.1739

Published: 2001

NARROW

Honeur (Heamatology Outcomes Network in Europe): A Federated Model to Support Real World Data Research in Hematology

Is Multiple Myeloma a Chronic Disease? A Population Based Study Comparing 1843 Patients to a Matched Swedish Population.

Is Renal Impairment Still a Poor Prognostic Marker in Myeloma Care?: A Population Based Study Including 1542 Patients

Follow-up of Real Life Treated Multiple Myeloma Patients: Response, Disease Progression and Overall Survival,

Optimal Treatment Sequencing In Multiple Myeloma: An Exploratory Modeling Approach

Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients after Stem Cell Transplantation.

Impact of Conditioning on the Outcome of Allografting in Myelofibrosis with Myeloid Metaplasia: Better Survival with Reduced Intensity Approach in Patients ≥50 Years.

Fatal Infectious Complications Developing Late after Allogeneic Stem Cell Transplantation.

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only